Kangmei Pharma | 600518 - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Genomma Lab Internacional MXN 3.32B 99.85M 2026-03
Hypermarcas BRL 1.59B 36.2M 2025-12
Ionis Pharmaceuticals USD 364M 54M 2026-03
IQVIA Holdings USD 1.69B 4.47B 2025-12
Jiangsu Hengrui CNY 5.52B 604.29M 2026-03
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Moderna USD 1.78B 242M 2026-03
Organon & Co USD 1.29B 384M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sh Fosun Pharma CNY 9.18B 2.12B 2026-03
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Wuxi Apptec CNY 7.84B 354.28M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03